Camber Pharmaceuticals adds 500 count to Generic Zetia®

Piscataway, NJ, July 18, 2024 – Camber Pharmaceuticals is pleased to announce the addition of Ezetimibe 500 count to its product line.
Last August, Camber launched the 10 mg of Ezetimibe Tablets in 30 and 90 count bottles.
Ezetimibe 10 mg Tablets are now available in 30, 90 and 500 count bottles.
To find out more about Ezetimibe Tablets, USP please visit www.camberpharma.com.
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection